Q1 saw a 0.8% decline in identical sales, with digital and pharmacy growth offset by core business pressures. The company is accelerating investments in customer value and launching the ACI Edge model to drive efficiency and long-term growth, while updating guidance to reflect a challenging demand environment.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.